Emerging role of antileukotriene therapy in allergic rhinitis.
Lipworth
B J
BJ
Asthma and Allergy Research Group, Department of Clinical Pharmacology & Therapeutics, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK. b.j.lipworth@dundee.ac.uk
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D009298:Nasal Polyps / Q000139:chemically induced; D012221:Rhinitis, Allergic, Perennial / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D018927:Anti-Asthmatic Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006633:Histamine Antagonists; D020024:Leukotriene Antagonists; D001241:Aspirin